Table 2.
Assay | CT (s) | CFT (s) | Angle α (°) | A10 (mm) | A20 (mm) | MCF (mm) | LI30 (%) | ML (%) in 1 h |
---|---|---|---|---|---|---|---|---|
EXTEM | 38–79 | 34–159 | 63–83 | 43–65 | 50–71 | 50–72 | 94–100 | <15 |
INTEM | 100–240 | 30–110 | 70–83 | 44–66 | 50–71 | 50–72 | 94–100 | <15 |
FIBTEM | - | - | - | 7–23 | 8–24 | 9–25 | - | - |
APTEM | A better clot formation in APTEM compared to EXTEM indicates an in vitro effect of antifibrinolytics (aprotinin and tranexamic acid) | |||||||
HEPTEM | A better clot formation in HEPTEM compared to INTEM indicates the presence of heparin or heparin-like anticoagulants |